Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?
The long-term use of immunosuppressive drugs following kidney transplantation increases the risk of life-threatening infections, malignancies, and, paradoxically, eventual allograft rejection. Therefore, achieving a balance between over-immunosuppression and under-immunosuppression is critical to op...
Saved in:
Main Authors: | Ahmad Matarneh, Meet Patel, Kinna Parikh, Amanda Karasinski, Gurwant Kaur, Vaqar Shah, Nasrollah Ghahramani, Naman Trivedi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Antibodies |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4468/14/2/49 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01) -
Unlocking the therapeutic potential of thymus-isolated regulatory T cells
by: Yueyuan Hu, et al.
Published: (2025-06-01) -
Role of the regulatory T cells CD4+CD25+ and mesenchymal marrow stem cells in suppressing a graft versus host reaction
by: I. A. Korsunsky, et al.
Published: (2022-11-01) -
REGULATORY T–CELLS: ORIGIN AND FUNCTION
by: I. S. Freidlin
Published: (2014-07-01) -
Regulatory T cell therapy in autoimmune liver disease and transplantationKeypoints
by: Maegen Fleming, et al.
Published: (2025-08-01)